ESSA Pharma Inc.
1.76
-0.01 (-0.56%)
At close: Jan 15, 2025, 3:59 PM
1.76
-0.28%
After-hours Jan 15, 2025, 04:00 PM EST

ESSA Pharma Statistics

Share Statistics

ESSA Pharma has 44.37M shares outstanding. The number of shares has increased by 0.3% in one year.

Shares Outstanding 44.37M
Shares Change (YoY) n/a
Shares Change (QoQ) 0%
Owned by Institutions (%) n/a
Shares Floating 43.38M
Failed to Deliver (FTD) Shares 90
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 691.47K, so 1.56% of the outstanding shares have been sold short.

Short Interest 691.47K
Short % of Shares Out 1.56%
Short % of Float 1.59%
Short Ratio (days to cover) 0.32

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -3.72.

PE Ratio 0
Forward PE -3.72
PS Ratio 0
Forward PS 3.5
PB Ratio 2.09
P/FCF Ratio -11.81
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for ESSA Pharma Inc..

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 38.64, with a Debt / Equity ratio of 0.

Current Ratio 38.64
Quick Ratio 38.64
Debt / Equity 0
Total Debt / Capitalization 0
Cash Flow / Debt 0
Interest Coverage 0

Financial Efficiency

Return on equity (ROE) is 0% and return on capital (ROIC) is 0%.

Return on Equity (ROE) 0%
Return on Assets (ROA) 0%
Return on Capital (ROIC) 0%
Revenue Per Employee 0
Profits Per Employee 0
Employee Count 50
Asset Turnover 0
Inventory Turnover 0

Taxes

Income Tax 0
Effective Tax Rate 0

Stock Price Statistics

The stock price has increased by -80.63% in the last 52 weeks. The beta is 1.84, so ESSA Pharma 's price volatility has been higher than the market average.

Beta 1.84
52-Week Price Change -80.63%
50-Day Moving Average 1.8
200-Day Moving Average 4.89
Relative Strength Index (RSI) 43.36
Average Volume (20 Days) 1.03M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income 0
Net Income 0
EBITDA 0
EBIT n/a
Earnings Per Share (EPS) -0.64
Full Income Statement

Balance Sheet

The company has 103.71M in cash and 329.26K in debt, giving a net cash position of 103.38M.

Cash & Cash Equivalents 103.71M
Total Debt 329.26K
Net Cash 103.38M
Retained Earnings 0
Total Assets 128.11M
Working Capital 124.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -22.72M and capital expenditures 0, giving a free cash flow of -22.72M.

Operating Cash Flow -22.72M
Capital Expenditures 0
Free Cash Flow -22.72M
FCF Per Share -0.51
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

EPIX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield -36.16%
FCF Yield -28.84%
Dividend Details

Analyst Forecast

The average price target for EPIX is $2, which is 13% higher than the current price. The consensus rating is "Hold".

Price Target $2
Price Target Difference 13%
Analyst Consensus Hold
Analyst Count 3
Stock Forecasts

Stock Splits

The last stock split was on Apr 25, 2018. It was a backward split with a ratio of 1:20.

Last Split Date Apr 25, 2018
Split Type backward
Split Ratio 1:20

Scores

Altman Z-Score 12.73
Piotroski F-Score 1